Ellevest Inc’s Neurogene NGNE Stock Holding History

Ellevest Inc’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3	Closed	–	–	1771
2022 Q2	$0	Buy	+3	New	+$73	﹤0.01%	1579
2022 Q1	–	Sell	-2	Closed	–	–	1559
2021 Q4	$0	Buy	2 +1	+100%	+$122	﹤0.01%	1567
2021 Q3	$0	Buy	+1	New	+$153	﹤0.01%	1516
2020 Q4	–	Sell	-7	Closed	-$2K	–	1295
2020 Q3	$2K	Buy	+7	New	+$1.7K	﹤0.01%	919

Other funds holding NGNE

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Ellevest Inc's NGNE Position: Q3 2022 in Review

Ellevest Inc sold out of Neurogene (NGNE) in Q3 2022, closing a stake of 3 shares.

Ellevest Inc first reported a position in NGNE in Q3 2020 and held it in 4 quarters. The position peaked at $2K in Q3 2020. 52 funds tracked by Wall St. Rank hold NGNE as of Q3 2022.

Ellevest Inc reported no remaining Neurogene position as of Q3 2022 after selling out during the quarter.
Ellevest Inc sold 3 Neurogene shares in Q3 2022.
Ellevest Inc first reported a position in Neurogene in Q3 2020 and held it in 4 quarters.
Ellevest Inc's Neurogene position peaked at $2K in Q3 2020.
52 funds tracked by Wall St. Rank held Neurogene as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.